SAba Sile
Corporate Officer/Principal presso SPRUCE BIOSCIENCES, INC.
Profilo
SAba Sile is currently the Vice President-Clinical Development at Spruce Biosciences, Inc. Prior to this, Sile worked as a Medical Director at BioMarin Pharmaceutical, Inc. and as an Executive Medical Director-Clinical Development at Horizon Therapeutics Plc.
Sile holds a doctorate degree from the University of Pittsburgh School of Medicine.
Posizioni attive di SAba Sile
| Società | Posizione | Inizio |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 10/11/2022 |
Precedenti posizioni note di SAba Sile
| Società | Posizione | Fine |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Formazione di SAba Sile
| University of Pittsburgh School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- SAba Sile
